Evidence map›Paper›PMID 35301688›Full record

ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2022

Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning.

R R van de Leur, H Bleijendaal, K Taha, T Mast, J M I H Gho, M Linschoten, B van Rees, M T H M Henkens, S Heymans, N Sturkenboom and 19 more

Open access · diamondAbstract read
In one paragraph

Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 13 institutions in 3 countries.

R R van de LeurDepartment of Cardiology, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
H BleijendaalDepartment of Clinical and Experimental Cardiology, Amsterdam University Medical Centres, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.
K TahaDepartment of Cardiology, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
T MastDepartment of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
J M I H GhoDepartment of Cardiology, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
M LinschotenDepartment of Cardiology, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
B van ReesDepartment of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
M T H M HenkensDepartment of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
S HeymansDepartment of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
N SturkenboomDepartment of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
R A TioDepartment of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
J A OfferhausDepartment of Clinical and Experimental Cardiology, Amsterdam University Medical Centres, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.
W L BorDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
M MaarseDepartment of Clinical and Experimental Cardiology, Amsterdam University Medical Centres, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.
H E Haerkens-ArendsDepartment of Cardiology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
M Z H KolkDepartment of Clinical and Experimental Cardiology, Amsterdam University Medical Centres, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.
A C J van der LingenDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam Cardiovascular Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
J J SelderDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam Cardiovascular Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
E E WierdaDepartment of Cardiology, Dijklander Hospital, Hoorn, The Netherlands.
P F M M van BergenDepartment of Cardiology, Dijklander Hospital, Hoorn, The Netherlands.
M M WinterDepartment of Clinical and Experimental Cardiology, Amsterdam University Medical Centres, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.
A H ZwindermanDepartment of Clinical Epidemiology, Biostatistics & Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.
P A DoevendansDepartment of Cardiology, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
P van der HarstDepartment of Cardiology, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Y M PintoDepartment of Clinical and Experimental Cardiology, Amsterdam University Medical Centres, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.
F W AsselbergsDepartment of Cardiology, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
R van EsDepartment of Cardiology, Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
F V Y TjongDepartment of Clinical and Experimental Cardiology, Amsterdam University Medical Centres, Heart Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands. f.v.tjong@amsterdamumc.nl.
CAPACITY-COVID collaborative consortium
University of Amsterdam · NLUtrecht University · NLAmsterdam University Medical Centers · NLCatharina Ziekenhuis · NLJeroen Bosch Ziekenhuis · NLMaastricht University · NLReinier de Graaf Hospital · NLVrije Universiteit Amsterdam · NLKU Leuven · BENetherlands Heart Institute · NLSt. Antonius Ziekenhuis · NLUniversity College London · GBUniversity Medical Center Utrecht · NL

Funding

dutch heart foundation 2020B006 CAPACITYeu/efpia innovative medicines initiative 2 joint undertaking bigdata@heart 116074fondation leducq CURE-PLaNnational institute for health research (nihr)/british heart foundation COVID-19 Flagship Research programmeZonMw 104021004ZonMw 2019-3-452019308
6 · The paper itself

Abstract

background and purposeThe electrocardiogram (ECG) is frequently obtained in the work-up of COVID-19 patients. So far, no study has evaluated whether ECG-based machine learning models have added value to predict in-hospital mortality specifically in COVID-19 patients.

methodsUsing data from the CAPACITY-COVID registry, we studied 882 patients admitted with COVID-19 across seven hospitals in the Netherlands. Raw format 12-lead ECGs recorded within 72 h of admission were studied. With data from five hospitals (n = 634), three models were developed: (a) a logistic regression baseline model using age and sex, (b) a least absolute shrinkage and selection operator (LASSO) model using age, sex and human annotated ECG features, and (c) a pre-trained deep neural network (DNN) using age, sex and the raw ECG waveforms. Data from two hospitals (n = 248) was used for external validation.

resultsPerformances for models a, b and c were comparable with an area under the receiver operating curve of 0.73 (95% confidence interval [CI] 0.65-0.79), 0.76 (95% CI 0.68-0.82) and 0.77 (95% CI 0.70-0.83) respectively. Predictors of mortality in the LASSO model were age, low QRS voltage, ST depression, premature atrial complexes, sex, increased ventricular rate, and right bundle branch block.

conclusionThis study shows that the ECG-based prediction models could be helpful for the initial risk stratification of patients diagnosed with COVID-19, and that several ECG abnormalities are associated with in-hospital all-cause mortality of COVID-19 patients. Moreover, this proof-of-principle study shows that the use of pre-trained DNNs for ECG analysis does not underperform compared with time-consuming manual annotation of ECG features.

Indexed as

ArrhythmiaCOVID-19Deep learningElectrocardiogramMachine learningMortality

Identifiers

PMID35301688
PMCPMC8929464
OpenAlexW4221081179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.